INCB47986
/ Incyte
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
May 28, 2014
INCB047986 in Rheumatoid Arthritis
(clinicaltrials.gov)
- P2; N=60; Recruiting; Sponsor: Incyte Corporation
New P2 trial • Biosimilar • Immunology • Renal Cell Carcinoma • Rheumatoid Arthritis
May 28, 2014
INCB047986 in Rheumatoid Arthritis
(clinicaltrials.gov)
- P2; N=60; Recruiting; Sponsor: Incyte Corporation; Not yet recruiting -> Recruiting
Enrollment open • Biosimilar • Immunology • Renal Cell Carcinoma • Rheumatoid Arthritis
February 23, 2015
INCB047986 in Rheumatoid Arthritis
(clinicaltrials.gov)
- P2; N=3; Terminated; Sponsor: Incyte Corporation; N=60 -> 3 ; Recruiting -> Terminated ; Trial primary completion date: May 2015 ->Aug 2014
Enrollment change • Trial primary completion date • Trial termination • Biosimilar • Immunology • Inflammation • Rheumatoid Arthritis
May 02, 2014
Incyte: Q1 2014 Results
(Incyte)
- Anticipated initiation of P2 trial in rheumatoid arthritis by mid-2014
Anticipated new P2 trial • Immunology
1 to 4
Of
4
Go to page
1